Koers Shengtai Pharmaceutical, Inc. Other OTC
Aandelen
SGTI
US8232142005
Farmaceutische producten
Omzet 2011 | 172 mln. 160 mln. | Omzet 2012 | 179 mln. 167 mln. | Marktkapitalisatie | 14,86 mln. 13,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2011 | 7 mln. 6,53 mln. | Nettowinst (verlies) 2012 | 1 mln. 933K | EV/omzet 2011 | 0,4 x |
Nettoschuld 2011 | 55,79 mln. 52,02 mln. | Nettoschuld 2012 | 86,75 mln. 80,89 mln. | EV/omzet 2012 | 0,57 x |
K/w-verhouding 2011 |
1,63
x | K/w-verhouding 2012 |
14,1
x | Werknemers | - |
Dividendrendement 2011 * |
-
| Dividendrendement 2012 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Qing Tai Liu
CHM | Chairman | 65 | - |
Yong Qiang Wang
BRD | Director/Board Member | 54 | 01-04-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Qing Tai Liu
CHM | Chairman | 65 | - |
Yong Qiang Wang
BRD | Director/Board Member | 54 | 01-04-06 |
Ji Hui Hao
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,26% | 43,18 mld. | |
+20,67% | 22,59 mld. | |
+15,11% | 14,56 mld. | |
+38,55% | 11,5 mld. | |
-8,37% | 6,93 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+10,21% | 5,36 mld. | |
-2,27% | 4,81 mld. |